Coming Soon
Find information on rosacea diagnosis, including ICD-10 codes (L71.0, L71.1, L71.8, L71.9), clinical documentation requirements, treatment options, and subtype classifications (erythematotelangiectatic rosacea, papulopustular rosacea, phymatous rosacea, ocular rosacea). Learn about diagnostic criteria, differential diagnoses, and best practices for healthcare professionals managing rosacea in clinical settings. Explore resources for accurate medical coding and billing related to rosacea.
Also known as
Rosacea
Inflammatory skin condition causing redness, pimples, and visible blood vessels.
Papulosquamous disorders
Skin conditions characterized by papules, scales, and plaques.
Diseases of the skin and subcutaneous tissue
Encompasses various skin and tissue disorders including infections, inflammations, and growths.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the diagnosis rosacea?
When to use each related code
| Description |
|---|
| Facial redness, visible blood vessels |
| Acne vulgaris (pimples) |
| Perioral dermatitis (rash) |
Coding L71.9 (Rosacea, unspecified) without specifying subtype (e.g., L71.0 for rhinophyma) when documented, leads to inaccurate severity and treatment reflection.
Failing to code ocular rosacea (H01.13) separately when present alongside skin manifestations (L71.-) can underestimate disease burden and impact reimbursement.
Miscoding rosacea (L71.-) as acne (L70.-) due to similar symptoms can lead to incorrect treatment plans and skewed epidemiological data.
Patient presents with complaints consistent with rosacea. Symptoms include facial erythema, specifically involving the cheeks, nose, and forehead. The patient reports experiencing flushing and blushing, with triggers including sun exposure, alcohol consumption, and spicy foods. Physical examination reveals telangiectasia and papules, though no pustules or nodules were observed at this time. The patient denies any ocular symptoms. Differential diagnoses considered included acne vulgaris, seborrheic dermatitis, and perioral dermatitis. Based on the clinical presentation and patient history, a diagnosis of erythematotelangiectatic rosacea subtype 1 is made. Patient education was provided regarding trigger avoidance, sun protection, and gentle skin care. Initial treatment plan includes topical metronidazole gel 1 twice daily. Follow-up appointment scheduled in four weeks to assess treatment response and adjust management as needed. ICD-10 code L71.9 Rosacea, unspecified is assigned. Medical billing codes for the evaluation and management visit and topical medication will be applied as appropriate.